BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY

BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY

Aim of the study Medication related osteonecrosis of the jaw (MRONJ) is a severe drug adverse effect, often being diagnosed in an advanced stage. The aim of this epidemiological study was to determine the frequency of MRONJ in cancer patients from Oltenia region, during 2012-2017. Material and metho...

Full description

Bibliographic Details
Main Authors:	George Adrian Ciobanu, Adrian Camen, Mihaela Ionescu, Daniel Vlad, Veronica Mercuț, Ionela Elisabeta Staicu, Gabriel Sebastian Petrescu, Adel Aila Asan, Sanda Mihaela Popescu
Format:	Article
Language:	English
Published:	Romanian Society of Oral Rehabilitation 2022-08-01
Series:	Romanian Journal of Oral Rehabilitation
Subjects:	bisphosphonate-associated osteonecrosis of the jaw diphosphonates mandible osteonecrosis neoplasms
Online Access:	https://www.rjor.ro/bisphosphonates-related-osteonecrosis-of-the-jaw-in-cancer-patients-epidemiological-study/

Similar Items

Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats
by: Felipe M. Silveira, et al.
Published: (2017-01-01)

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review
by: Aloizio Premoli Maciel, et al.
Published: (2020-07-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012-01-01)

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy
by: Zuzana Janovská
Published: (2012-01-01)

Bisphosphonate-associated jaw osteonecrosis in the treatment of rheumatoid arthritis
by: Gabriela Dias Rosso dos Santos, et al.
Published: (2024-11-01)

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw
by: Zuzana Janovska, et al.
Published: (2015-06-01)

Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw
by: Antonio Cortese, et al.
Published: (2021-04-01)

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

Topical erythropoietin as a novel preventive and therapeutic agent in bisphosphonate-related osteonecrosis of the jaw
by: Pantea Nazeman, et al.
Published: (2016-01-01)

Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014-09-01)

Osteonecrosis of the jaw as a serious adverse effect of bisphosphonate therapy and its indistinct etiopathogenesis
by: Gavrić Miodrag, et al.
Published: (2014-01-01)

The Use of Imaging Methods in the Diagnosis of Bisphosphonate-related Osteonecrosis of the Jaw
by: L. Hauer, et al.
Published: (2012-03-01)

Osteonecrosis of the Jaws in Treatment with Bisphosphonates
by: M. Machálka, et al.
Published: (2006-12-01)

A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosis
by: Roberto Sacco, et al.
Published: (2011-08-01)

Obesity influences the development of bisphosphonate-induced osteonecrosis in Wistar rats
by: Wilson José de Miranda LIMA, et al.
Published: (2023-09-01)

Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws
by: Conte-Neto Nicolau, et al.
Published: (2012-03-01)

A Case of Autoimmune Hepatitis and Bisphosphonate-Related Osteonecrosis of the Jaw
by: Y.S. de Boer, et al.
Published: (2012-05-01)

Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01)

Knowledge Level of Physicians Prescribing Bisphosphonates: Prevention and Treatment of Medication-Related Osteonecrosis of the Jaw
by: Tahereh Padeganeh, et al.
Published: (2024-10-01)

Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
by: Seung-Hun Lee, et al.
Published: (2021-07-01)

Bisphosphonate-related osteonecrosis of the jaws: Report of two cases with breast cancer, a dental concern and review of the literature
by: Ahmet Ercan Şekerci, et al.
Published: (2012-07-01)

A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats
by: Suzanna L. Hatunen, et al.
Published: (2024-08-01)

Systematic Review on the Incidence of Bisphosphonate Related Osteonecrosis of the Jaw in Children Diagnosed with Osteogenesis Imperfecta
by: Anusha Adeline Hennedige, et al.
Published: (2014-01-01)

Medication-related osteonecrosis of jaw and rheumatoid arthritis: Revisiting the concepts
by: Adity Bansal, et al.
Published: (2021-01-01)

Bisphosphonates and osteonecrosis of the jaw /
by: Bilezikian, John P., et al.
Published: (2011)

What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?
by: Mihai Vlad Golu, et al.
Published: (2022-09-01)

Histopathological assessment of the preventive effect of leukocyte-platelet-rich fibrin on bisphosphonate-related osteonecrosis of the jaw following dental extraction: An animal study
by: Milad Etemadi Sh, et al.
Published: (2023-07-01)

Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw
by: Giuseppina Campisi, et al.
Published: (2012-01-01)

EPIDEMIOLOGICAL INVESTIGATION OF THE CLINICAL MANIFESTATION OF BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAWS IN 112 ONCOLOGY PATIENTS
by: Meri Hristamyan, et al.
Published: (2025-02-01)

Bisphosphonate related osteonecrosis of jaw: A case report
by: Waquar Ahmed, et al.
Published: (2017-01-01)

The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw
by: Weidong Zhang, et al.
Published: (2021-02-01)

ADVANCED-PLATELET RICH FIBRIN – A NEW ACQUISITION IN JAW OSTEONECROSIS TREATMENT
by: Daniel Vlad, et al.
Published: (2018-01-01)

Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
by: Vincenzi Bruno, et al.
Published: (2012-09-01)

Bisphosphonates: An update to the general dentist
by: Varun Dahiya, et al.
Published: (2013-01-01)

Review of the effect of biphosphonates on jaw osteonecrosis
by: Afshin Tahmasebi, et al.
Published: (2011-01-01)

Absence of medication-related jaw osteonecrosis after treatment with strontium ranelate in ovariectomized rats
by: Leomar Emanuel de Almeida MECCA, et al.
Published: (2022-06-01)

Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
by: Yusuke Zushi, et al.
Published: (2017-03-01)

Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using competing inert hydroxymethylene diphosphonate
by: Hiroko Okawa, et al.
Published: (2022-08-01)

Skin involvement of medication-related osteonecrosis of jaws in an immunocompromised, bisphosphonate-treated patient
by: Ye Eun Kim, MD, et al.
Published: (2022-02-01)